Functional variation among mesenchymal stem cells derived from different tissue sources
Open Access
Abstract
Background: Mesenchymal stem cells (MSCs) are increasingly recognized for their regenerative potential. However, their clinical application is hindered by their inherent variability, which is influenced by various factors, such as the tissue source, culture conditions, and passage number. Methods: MSCs were sourced from clinically relevant tissues, including adipose tissue-derived MSCs (ADMSCs, n = 2), chorionic villi-derived MSCs (CMMSCs, n = 2), amniotic membrane-derived MSCs (AMMSCs, n = 3), and umbilical cord-derived MSCs (UCMSCs, n = 3). Passages included the umbilical cord at P0 (UCMSCP0, n = 2), P3 (UCMSCP3, n = 2), and P5 (UCMSCP5, n = 2) as well as the umbilical cord at P5 cultured under low-oxygen conditions (UCMSCP5L, n = 2). Results: We observed that MSCs from different tissue origins clustered into six distinct functional subpopulations, each with varying proportions. Notably, ADMSCs exhibited a higher proportion of subpopulations associated with vascular regeneration, suggesting that they are beneficial for applications in vascular regeneration. Additionally, CMMSCs had a high proportion of subpopulations associated with reproductive processes. UCMSCP5 and UCMSCP5L had higher proportions of subpopulations related to female reproductive function than those for earlier passages. Furthermore, UCMSCP5L, cultured under low-oxygen (hypoxic) conditions, had a high proportion of subpopulations associated with pro-angiogenic characteristics, with implications for optimizing vascular regeneration. Conclusions: This study revealed variation in the distribution of MSC subpopulations among different tissue sources, passages, and culture conditions, including differences in functions related to vascular and reproductive system regeneration. These findings hold promise for personalized regenerative medicine and may lead to more effective clinical treatments across a spectrum of medical conditions.Keywords
Funding Information
- National Natural Science Foundation of China (82271644)
This publication has 46 references indexed in Scilit:
- Evaluation of Safety and Efficacy of Amniotic Mesenchymal Stem Cells for POI in AnimalsReproductive Sciences, 2023
- Exploring the future potential of mesenchymal stem/stromal cells and their derivatives to support assisted reproductive technology for female infertility applicationsHuman Cell, 2023
- Developing Standards to Support the Clinical Translation of Stem CellsStem Cells Translational Medicine, 2021
- Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical usesCellular and Molecular Life Sciences, 2020
- Mesenchymal stem cells for restoring endometrial function: An infertility perspectiveReproductive Medicine and Biology, 2020
- Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesisCellular and Molecular Life Sciences, 2019
- Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic ReviewStem Cell Reviews and Reports, 2017
- Amniotic membrane mesenchymal stem cells can differentiate into germ cells in vitroIn Vitro Cellular & Developmental Biology - Animal, 2016
- Chorionic Villi: Histology and Villous Development2010
- Differentiation of human umbilical cord Wharton's jelly‐derived mesenchymal stem cells into germ‐like cells in vitroJournal of Cellular Biochemistry, 2010